J&J Falls 4% as Medtech Sales Miss, Plans Orthopedics Spinoff in 2027
J&J Q3 earnings beat but medtech sales missed due to Middle East conflict. Guidance raised but below Street. Orthopedics spinoff planned for mid-2027. Stock fell 4%+. 59 clean stories shaped this window, with sentiment bullish at 60/100. Also in focus: JPMorgan Q3 adjusted EPS $5.75, revenue $50.2B miss estimates; shares down 2.8% premarket.
Sentiment60/100 · Bullish
Market readBullishat publication
Stories59clean stories in the window
Published12:30 PMTue, Oct 13 · ET